Ballentine Partners LLC Sells 4,138 Shares of Healthpeak Properties, Inc. $DOC

Ballentine Partners LLC lessened its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 23.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 13,856 shares of the real estate investment trust’s stock after selling 4,138 shares during the quarter. Ballentine Partners LLC’s holdings in Healthpeak Properties were worth $243,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of DOC. Avanza Fonder AB acquired a new stake in shares of Healthpeak Properties in the second quarter worth $960,000. Farther Finance Advisors LLC boosted its stake in shares of Healthpeak Properties by 10.2% in the 2nd quarter. Farther Finance Advisors LLC now owns 14,199 shares of the real estate investment trust’s stock valued at $249,000 after purchasing an additional 1,315 shares in the last quarter. CX Institutional boosted its stake in shares of Healthpeak Properties by 11.9% in the 2nd quarter. CX Institutional now owns 6,820 shares of the real estate investment trust’s stock valued at $119,000 after purchasing an additional 726 shares in the last quarter. UMB Bank n.a. boosted its stake in shares of Healthpeak Properties by 102.5% in the 2nd quarter. UMB Bank n.a. now owns 3,730 shares of the real estate investment trust’s stock valued at $65,000 after purchasing an additional 1,888 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its stake in shares of Healthpeak Properties by 52.3% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 529,236 shares of the real estate investment trust’s stock valued at $9,643,000 after purchasing an additional 181,708 shares in the last quarter. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $19.00 on Tuesday. The stock’s 50-day simple moving average is $17.81 and its 200 day simple moving average is $18.03. The firm has a market capitalization of $13.20 billion, a PE ratio of 79.17, a price-to-earnings-growth ratio of 2.44 and a beta of 1.07. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. Healthpeak Properties, Inc. has a twelve month low of $16.63 and a twelve month high of $23.26.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts’ consensus estimates of $0.46. The firm had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The business’s revenue for the quarter was down .2% on a year-over-year basis. During the same period last year, the firm posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 18th were issued a $0.1017 dividend. This represents a c) dividend on an annualized basis and a yield of 6.4%. The ex-dividend date was Monday, August 18th. Healthpeak Properties’s payout ratio is presently 508.33%.

Insider Activity at Healthpeak Properties

In other news, CEO Scott M. Brinker acquired 1,490 shares of the firm’s stock in a transaction dated Monday, August 4th. The stock was purchased at an average price of $16.83 per share, for a total transaction of $25,076.70. Following the completion of the acquisition, the chief executive officer directly owned 211,906 shares in the company, valued at $3,566,377.98. The trade was a 0.71% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders purchased a total of 8,783 shares of company stock worth $150,129 in the last ninety days. Insiders own 0.23% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $18.00 price target (down previously from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Wells Fargo & Company lowered their price target on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 27th. Scotiabank cut Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and lowered their target price for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Wall Street Zen downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Monday, July 7th. Finally, Robert W. Baird set a $21.00 price target on Healthpeak Properties and gave the stock an “outperform” rating in a research report on Wednesday, July 30th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $21.45.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.